~~<i id='AAA733C271'><strike id='AAA733C271'><tt id='AAA733C271'><pre id='AAA733C271'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：knowledge 2025-10-02 06:54:07 Page View：1932

Biotech and life sciences investors continue to draw in new funds even as the biotech stock indexes reach new lows.

On Wednesday, VC firm Bioluminescence Ventures launched with $477 million to invest in biotech startups. The firm was founded by Kouki Harasaki, who was previously a partner at M12, Microsoft’s corporate venture group, and Andreessen Horowitz. He also has a track record at pharmaceutical companies like Novartis and Baxalta.

Bioluminescence joined at least four other firms — OrbiMed, Sofinnova Partners, Abingworth, and Revelation Partners — in announcing new pools of capital in the last two weeks. Together, they have raised $5.94 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Congress must protect the remaining independent doctors
Next article： Heart attack and stroke risk calculators need revising

leisure time

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

Congress might make insulin pumps more accessible to the blind

AdobeKatieKeimwasdiagnosedwithtype1diabetesin1967whenshewaseight,wellbeforetheeraofinsulinpumpsoreve

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Telehealth startups turn to complex chronic diseases

MollyFergusonforSTATIfherneurologistmovedtoChina,LaurenStilessaysshe’dfollowhimthere.“There’ssofewdo